GoodRx Holdings, Inc. (GDRX) vs SOPHiA GENETICS SA (SOPH)
- GoodRx Holdings, Inc. GDRX 3.49 0.00%
- SOPHiA GENETICS SA SOPH 7.09 +7.10%
GoodRx Holdings, Inc. and SOPHiA GENETICS SA are both Health Information Services companies. GoodRx Holdings, Inc. is the larger, with a market value of $1.2B against $563.6M — 2.1× the size. SOPHiA GENETICS SA has negative trailing earnings, so its P/E is not meaningful; GoodRx Holdings, Inc. trades at 65.7×. SOPHiA GENETICS SA grew revenue faster over the last twelve months: 24.1% against −1.83%. GoodRx Holdings, Inc. has the higher net margin (2.07% vs −89.2%) and the higher return on invested capital (5.59% vs −200.9%). Across the 18 metrics below, GoodRx Holdings, Inc. leads on 13 and SOPHiA GENETICS SA on 5.
Valuation
Profitability
| Metric | GDRX | SOPH | Health Information Services median |
|---|---|---|---|
| Gross margin | 90.83% | 66.43% | 59.61% |
| Operating margin | 9.54% | (80.99%) | (10.54%) |
| Net margin | 2.07% | (89.18%) | (16.14%) |
| Free cash flow margin | 16.77% | (45.64%) | 0.00% |
| Return on equity | 2.52% | (125.67%) | (3.15%) |
| Return on assets | 0.89% | (46.60%) | (5.62%) |
| Return on invested capital | 5.59% | (200.89%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack